当前位置:首页 - 行情中心 - 华海药业(600521) - 财务分析

华海药业

(600521)

  

流通市值:253.78亿  总市值:253.78亿
流通股本:14.97亿   总股本:14.97亿

华海药业(600521)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润3.98亿元,每股收益0.27元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益985450.55万元,未分配利润584635.84万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产2221624.55万元,负债1236174.00万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入2,335,389,955.128,587,145,652.086,408,881,906.054,516,353,788.97
营业总成本2,158,801,767.768,145,904,767.725,972,319,712.384,001,688,219.95
其他经营收益
营业利润444,138,298.26456,461,342.57555,157,968.34541,255,245.22
利润总额444,333,566.17443,877,072549,156,742.39542,860,973.47
净利润398,341,441.17227,329,393.11373,930,103.93405,158,861.54
每股收益
其他综合收益-1,212,216.33-4,256,027.25-343,912.192,468,726.33
综合收益总额397,129,224.84223,073,365.86373,586,191.74407,627,587.87
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计9,218,844,183.528,742,273,876.098,647,950,847.318,899,110,228.73
非流动资产:
非流动资产合计12,997,401,296.6812,760,689,903.2912,504,740,748.0912,366,788,240.75
资产总计22,216,245,480.221,502,963,779.3821,152,691,595.421,265,898,469.48
流动负债:
流动负债合计9,104,719,827.989,112,383,431.936,534,113,590.565,699,401,455.32
非流动负债:
非流动负债合计3,257,020,130.992,934,543,685.315,018,993,002.435,561,365,499.73
负债合计12,361,739,958.9712,046,927,117.2411,553,106,592.9911,260,766,955.05
所有者权益(或股东权益):
归属于母公司股东权益合计9,846,959,231.059,442,683,809.879,509,925,669.119,910,300,224.43
股东权益合计9,854,505,521.239,456,036,662.149,599,585,002.4110,005,131,514.43
负债和股东权益合计22,216,245,480.221,502,963,779.3821,152,691,595.421,265,898,469.48
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计2,589,999,275.729,172,174,471.26,901,295,948.684,598,112,323.59
经营活动现金流出小计2,191,366,662.147,942,085,902.316,248,909,276.544,228,474,611.06
经营活动产生的现金流量净额398,632,613.581,230,088,568.89652,386,672.14369,637,712.53
投资活动产生的现金流量:
投资活动现金流入小计4,092,685217,644,946.34194,618,841.5876,504,440.78
投资活动现金流出小计580,811,602.822,085,198,669.651,303,981,134.49875,424,761.71
投资活动产生的现金流量净额-576,718,917.82-1,867,553,723.31-1,109,362,292.91-798,920,320.93
筹资活动产生的现金流量:
筹资活动现金流入小计1,180,000,0005,517,361,945.884,245,589,245.882,144,748,145.88
筹资活动现金流出小计555,354,722.274,900,292,154.223,888,396,173.241,615,705,090.56
筹资活动产生的现金流量净额624,645,277.73617,069,791.66357,193,072.64529,043,055.32
汇率变动对现金及现金等价物的影响-47,290,591.29-10,650,693.14-10,772,784.367,777,954.17
现金及现金等价物净增加额399,268,382.2-31,046,055.9-110,555,332.49107,538,401.09
期末现金及现金等价物余额1,845,822,546.311,446,554,164.111,367,044,887.521,585,138,621.1
补充资料:
现金及现金等价物的净增加额--31,046,055.9-107,538,401.09
最新报告期:2026-05-07
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
招商证券侯彪,梁广楷,许菲菲0.530.570.602026-05-07
中金公司张琎,吴婉桦0.390.33--2026-05-01
华创证券郑辰,王宏雨0.220.460.602026-03-31
TOP↑